Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 12/2014

01-12-2014 | Letter to the Editor

Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib

Authors: V. Vergote, D. Dierickx, A. Janssens, G. Verhoef, T. Tousseyn, P. Vandenberghe, P. Wolter, M. Delforge

Published in: Annals of Hematology | Issue 12/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
Dietrich S, Glimm H, Andrulis M et al (2012) BRAF inhibition in refractory hairy-cell leukemia. N Engl J Med 366:2038–2040PubMedCrossRef
3.
Follows G, Sims H, Bloxham D et al (2013) Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib. Br J Haematol 161:150–153PubMedCrossRef
4.
Munoz J, Schlette E, Kurzrock R (2013) Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation. J Clin Oncol 31:e351–e352PubMedCrossRef
5.
Dietrich S, Hüllein S, Hundemer M et al (2013) Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia. J Clin Oncol 31:e300–e303PubMedCrossRef
6.
Maurer H, Haas P, Wengenmayer T, Lübbert M, Duyster J, Zeiser R. Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis. Ann Hematol. 2013; Dec 14. [Epub ahead of print]
7.
Peyrade F, Re D, Ginet C et al (2013) Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation. Haematologica 98:e20–e22PubMedCentralPubMedCrossRef
8.
9.
10.
Andritsos L, Blachly J, Kendra K, Lozanski G, Grever M (2013) Co-treatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib. Blood 122:5311
11.
Anforth R, Fernandez-Peñas P, Long GV (2013) Cutaneous toxicities of RAF inhibitors. Lancet Oncol 14(1):e11–e18PubMedCrossRef
Metadata
Title
Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib
Authors
V. Vergote
D. Dierickx
A. Janssens
G. Verhoef
T. Tousseyn
P. Vandenberghe
P. Wolter
M. Delforge
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 12/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2104-2

Other articles of this Issue 12/2014

Annals of Hematology 12/2014 Go to the issue

Letter to the Editor

Association of growth differentiation factor 15 (GDF15) polymorphisms with serum GDF15 and ferritin levels in β-thalassemia

Original Article

Vitamin D deficiency and its correction in children with sickle cell anaemia

Original Article

Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years’ follow-up in Egypt

Original Article

Sleep problems and psychological distress in family members of patients with hematological malignancies in the Japanese population

Original Article

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea

Original Article

Enhancement of the cytotoxic activity of cytokine-induced killer cells transfected with IL3PE38KDEL gene against acute myeloid leukemia cells
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits